I think doing some re-testing in the 6s and seeing a bit of volume here is healthy.
I expect newsflow in June before that first batch of oppies can be exercised. But I would really like to see the detailed analysis of the SAD study, details on the Peach study especially since Paul hinted at a treatment arm to the study now. And when the FDA meeting will be and after they have it some details on the outcomes.
Ann: Grant funding to directly support Phase 2a trial, page-27
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.040(33.3%) |
Mkt cap ! $24.94M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 16.0¢ | 13.0¢ | $66.90K | 472.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 245030 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| ILA (ASX) Chart |